The adopter trade was finished before Wall Street named it
Wall Street's advice to rotate from AI infrastructure into "adopters" arrived this week as the last signature on a move the industry itself had been executing since February.
OpenAI cut its 2030 infrastructure plan from $1.4 trillion to about $600 billion in February, to line the buildout up with a $280 billion revenue forecast. [1] Nine months later, this week, Goldman Sachs said the industry's capital expenditure — money spent on chips, land, and data centers rather than day-to-day operations — would grow more slowly "for the first time." [2] The gap between those two dates is the whole trade. By September the labs had turned themselves into installation businesses. Microsoft created a Frontier company staffed with 6,000 forward-deployed engineers and a $2.5 billion commitment, to embed models in customers' systems; AWS put up $1 billion for the same push; OpenAI launched a deployment company of its own. [3] By mid-October the top models from Anthropic, OpenAI, Meta, and Google had reached near-parity — raw capability was no longer the differentiator. [4] October brought the funds' paperwork — the quarterly filings in which big investors disclose what they held three months earlier. Viking Global had sold its entire Apple stake; Appaloosa had exited Microsoft. The money moved into retail, home improvement, and pharma, with Eli Lilly the standout destination. [5] The lab resized in February, the installers deployed in September, the funds had filed their rotation by October. Every party executed before anyone advised. This week the trails crossed. Anthropic's S-1 — the filing that takes a company public — prices the record $1.4-to-$1.5 trillion IPO, backed by an $81 billion run rate, annualized revenue, and it makes its case on adoption, not intelligence. [6]
In the life sciences sector, where annual global pharmaceutical spend is expected to exceed $2 trillion in 2026, Claude is used in drug discovery and development by our customers, our biotechnology partners, and our own researchers — Anthropic
Eli Lilly, the funds' summer destination, became the lab's published exhibit: more than 85% of its 50,000 employees already use Claude. [7] Goldman's advice arrived this week — three weeks after JPMorgan's private bank made the same call [8] — the last signature on a stack that was already signed. [2] It told clients to move out of AI infrastructure and into adopters with physical businesses: ExxonMobil, GM, Waste Management. The same day, Nvidia reported revenue up 103% and guided its next quarter above consensus. [9] Demand is not rolling over. The rotation already has. The catch is already in the data. MIT's tracking found 95% of enterprise AI pilots produced no measurable effect on profit and loss. [10] And the S-1 carries its own exit clause — large customers may choose to build their own AI internally, and two customers already supply roughly a quarter of revenue. [6]
Large companies that are currently our customers may choose to develop their own AI capabilities internally rather than purchase our models. — Anthropic
One word closes it. "Adopter" is the name the desks gave the party the industry's own paperwork treats as a billable customer. The trade buys the billing layer, not an AI dividend.
- 1. OpenAI Cuts Infrastructure Spend to $600 Billion Ahead of IPO
- 2. Goldman Sachs Advises Shift Toward AI Adopter Stocks
- 3. AI Giants Commit Billions to Enterprise Deployment Services
- 4. Top AI Models Reach Parity as Market Focus Shifts
- 5. Hedge Funds Exit Major AI and Tech Stocks
- 6. Anthropic Targets $1.5 Trillion Valuation in Record-Breaking IPO
- 7. Anthropic Files for IPO With Pivot to Life Sciences
- 8. JPMorgan Private Bank Urges Shift Toward AI Adopters
- 9. Nvidia Corporation Revenue Surges 103 Percent to $115.8 Billion
- 10. Enterprise Agentic AI Pilots Fail Due to Data Gaps